Lummy Pharma Strikes Deal to Sell First Erectile Dysfunction Drug in China
Tang Shihua
DATE:  Feb 20 2019
/ SOURCE:  yicai
Lummy Pharma Strikes Deal to Sell First Erectile Dysfunction Drug in China Lummy Pharma Strikes Deal to Sell First Erectile Dysfunction Drug in China

(Yicai Global) Feb. 19 -- Lummy  Pharmaceutical has agreed a deal to act as exclusive sales agent for the  first generic drug for erectile dysfunction treatment on the Chinese  market.

The Chongqing-based firm's Lummy Medicine  unit has signed a sales authorization agreement with Haiyue  Pharmaceutical, according to a statement. Haiyue obtained approval from  the country's regulator to produce Tadalafil yesterday.

US firm Eli Lilly and Company introduced the drug at home in 2003 and it has led the US market for over a decade. 

Lummy  Medicine will organize, develop and promote the product in China, with  both parties to negotiate annual sales targets. The company will become a  permanent exclusive sales agent if it achieves the agreed goal during  the first three years of cooperation, the statement said. 

Editor: William Clegg

Follow Yicai Global on
Keywords:   Exclusive Selling Rights,Regional Market,Tadalafil Tablet,Erectile Dysfunction,Lummy Pharmaceutical